Mitsunobu Kawamura

2.2k total citations
72 papers, 1.8k citations indexed

About

Mitsunobu Kawamura is a scholar working on Surgery, Organic Chemistry and Molecular Biology. According to data from OpenAlex, Mitsunobu Kawamura has authored 72 papers receiving a total of 1.8k indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Surgery, 14 papers in Organic Chemistry and 12 papers in Molecular Biology. Recurrent topics in Mitsunobu Kawamura's work include Lipoproteins and Cardiovascular Health (10 papers), Antioxidant Activity and Oxidative Stress (10 papers) and Cholesterol and Lipid Metabolism (7 papers). Mitsunobu Kawamura is often cited by papers focused on Lipoproteins and Cardiovascular Health (10 papers), Antioxidant Activity and Oxidative Stress (10 papers) and Cholesterol and Lipid Metabolism (7 papers). Mitsunobu Kawamura collaborates with scholars based in Japan, United States and Greece. Mitsunobu Kawamura's co-authors include Alan Chait, Jay W. Heinecke, Lucy A. Suzuki, Yorihiro Yamamoto, Miwako Mori, Masanori Takimoto, Tanenao Eto, Yoshitaka Yamamoto, Shuichi Hisanaga and Shigeru Miyazaki and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Clinical Investigation and PLoS ONE.

In The Last Decade

Mitsunobu Kawamura

70 papers receiving 1.7k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Mitsunobu Kawamura Japan 22 389 377 266 257 244 72 1.8k
Yuichi Ishikawa Japan 22 514 1.3× 305 0.8× 294 1.1× 178 0.7× 153 0.6× 75 1.6k
Karl Oettl Austria 25 786 2.0× 300 0.8× 151 0.6× 165 0.6× 193 0.8× 66 2.3k
Guido Lazzerini Italy 23 417 1.1× 359 1.0× 397 1.5× 390 1.5× 170 0.7× 50 2.3k
Bogusław Lipiński United States 32 568 1.5× 228 0.6× 216 0.8× 317 1.2× 188 0.8× 102 3.2k
Carmen Domı́nguez Spain 25 442 1.1× 176 0.5× 106 0.4× 283 1.1× 112 0.5× 60 2.4k
Simona Bartimoccia Italy 29 407 1.0× 565 1.5× 518 1.9× 248 1.0× 258 1.1× 92 2.8k
William Strauss United States 24 939 2.4× 339 0.9× 671 2.5× 108 0.4× 510 2.1× 76 3.6k
Serena Del Turco Italy 29 460 1.2× 411 1.1× 469 1.8× 374 1.5× 85 0.3× 90 2.6k
Mark Hicks Australia 26 873 2.2× 693 1.8× 108 0.4× 85 0.3× 140 0.6× 86 2.5k
W.J.H. Vermaak South Africa 22 390 1.0× 716 1.9× 130 0.5× 134 0.5× 76 0.3× 67 2.4k

Countries citing papers authored by Mitsunobu Kawamura

Since Specialization
Citations

This map shows the geographic impact of Mitsunobu Kawamura's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mitsunobu Kawamura with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mitsunobu Kawamura more than expected).

Fields of papers citing papers by Mitsunobu Kawamura

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mitsunobu Kawamura. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mitsunobu Kawamura. The network helps show where Mitsunobu Kawamura may publish in the future.

Co-authorship network of co-authors of Mitsunobu Kawamura

This figure shows the co-authorship network connecting the top 25 collaborators of Mitsunobu Kawamura. A scholar is included among the top collaborators of Mitsunobu Kawamura based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mitsunobu Kawamura. Mitsunobu Kawamura is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Asakawa, M, et al.. (2015). Efficacy and safety of sitagliptin for the treatment of diabetes mellitus complicated by chronic liver injury. SpringerPlus. 4(1). 346–346. 16 indexed citations
3.
Sakamoto, Kentaro Q., Mitsunobu Kawamura, Takahide Kohro, et al.. (2015). Effect of Ezetimibe on LDL-C Lowering and Atherogenic Lipoprotein Profiles in Type 2 Diabetic Patients Poorly Controlled by Statins. PLoS ONE. 10(9). e0138332–e0138332. 26 indexed citations
4.
Hayashi, Hiroshi & Mitsunobu Kawamura. (2013). Lowering LDL cholesterol, but not raising LDL receptor activity, by ezetimibe. Journal of clinical lipidology. 7(6). 632–636. 5 indexed citations
5.
Sato, Yoshihiro, Masanori Takimoto, Mitsunobu Kawamura, & Miwako Mori. (2011). Nickel-Promoted Carboxylation/Cyclization Cascade of Allenyl Aldehyde under an Atmosphere of CO2. Synlett. 2011(10). 1423–1426. 9 indexed citations
6.
Sato, Takashige, Masakazu Nagafuku, Seiichi Tagami, et al.. (2008). Circulating levels of ganglioside GM3 in metabolic syndrome: A pilot study. Obesity Research & Clinical Practice. 2(4). 231–238. 36 indexed citations
7.
Yokota, Hiromitsu, Yoshiaki Hashimoto, Shigeo Okubo, et al.. (2002). Apolipoprotein A-I deficiency with accumulated risk for CHD but no symptoms of CHD. Atherosclerosis. 162(2). 399–407. 24 indexed citations
8.
Kawamura, Mitsunobu, et al.. (2001). [Effect of professional training on dental health attitudes of Israeli dental students].. PubMed. 18(2). 51–6, 63. 10 indexed citations
9.
Huang, Weitong, Kengo Moriyama, Takafumi Koga, et al.. (2001). Novel mutations in ABCA1 gene in Japanese patients with Tangier disease and familial high density lipoprotein deficiency with coronary heart disease. Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease. 1537(1). 71–78. 29 indexed citations
10.
Ohmori, Takao, Masaru Nakaiwa, Takashi Amemiya, Tsuyoshi Yamaguchi, & Mitsunobu Kawamura. (1998). Nonlinear Operation in a Chemical Reaction System Converting Methanol to Light Olefins. 135(3). 361–370. 1 indexed citations
11.
Teramoto, Tamio, et al.. (1996). Characterization of low-density-lipoprotein in apolipoprotein E deficiency in a patient without coronary atherosclerosis. Clinica Chimica Acta. 247(1-2). 159–166. 2 indexed citations
12.
Kawamura, Mitsunobu, Jay W. Heinecke, & Alan Chait. (1994). Pathophysiological concentrations of glucose promote oxidative modification of low density lipoprotein by a superoxide-dependent pathway.. Journal of Clinical Investigation. 94(2). 771–778. 209 indexed citations
13.
Iguchi, Sadahiko, H. IWAMURA, Mitsuhiro Nishizaki, et al.. (1992). Development of a Highly Cardioselective Ultra Short-Acting .BETA.-Blocker, ONO-1101.. Chemical and Pharmaceutical Bulletin. 40(6). 1462–1469. 164 indexed citations
14.
Yamamoto, Yorihiro, Mitsunobu Kawamura, Kenji Tatsuno, Etsuo Niki, & Chikayuki NAITO. (1990). Formation of lipid hydroperoxides in the cupric ion-induced oxidation of plasma and low density lipoprotein. Free Radical Biology and Medicine. 9. 66–66. 3 indexed citations
15.
Hayashi, Hiroshi, Chikayuki NAITO, Ito H, Mitsunobu Kawamura, & Shigeru Miyazaki. (1990). The Effect of Pravastatin in Relation to Low Density Lipoprotein Receptor Activity. Current Medical Research and Opinion. 12(2). 100–107. 5 indexed citations
16.
Ito, Hiroo, Chikayuki NAITO, Hiroshi Hayashi, Mitsunobu Kawamura, & Shigeru Miyazaki. (1989). Selective Removal of Triglyceride‐Rich Lipoproteins by Plasmapheresis in Diabetic Patients with Severe Hypertriglyceridemia. Artificial Organs. 13(3). 190–196. 5 indexed citations
17.
H, Ito, Chikayuki NAITO, Hiroshi Hayashi, & Mitsunobu Kawamura. (1988). Activity of low-density lipoprotein receptors as estimated from concentrations of apolipoprotein B and C-II in serum.. Clinical Chemistry. 34(11). 2224–2227. 8 indexed citations
18.
Kawamura, Mitsunobu, et al.. (1987). Studies on the Relationship between the Biodistribution of 45Ti-AsA in the Rat Kidney and Renal Functlons. 1987. 182–189. 1 indexed citations
19.
20.
Kawamura, Mitsunobu, et al.. (1987). Spontaneous Passage of Renal Calculi through Nephrocutaneous Fistula due to Calculous Pyelonephritis. British Journal of Urology. 59(3). 285–286. 6 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Yuichi Ishikawa Breakdown of academic impact, for papers by Karl Oettl Breakdown of academic impact, for papers by Guido Lazzerini Breakdown of academic impact, for papers by Bogusław Lipiński Breakdown of academic impact, for papers by Carmen Domı́nguez Breakdown of academic impact, for papers by Simona Bartimoccia Breakdown of academic impact, for papers by William Strauss Breakdown of academic impact, for papers by Serena Del Turco Breakdown of academic impact, for papers by Mark Hicks Breakdown of academic impact, for papers by W.J.H. Vermaak
Rankless by CCL
2026